Tag Archives: partnership

Friday’s big time losers and the reasons why (MBLX, DMND, PCX)

Posted on January 13, 2012 by Martin Timble

In this report: Metabolix (NASDAQ:MBLX), Diamond Foods (NASDAQ:DMND) and Patriot Coal Corp. (NYSE:PCX)

Metabolix (NASDAQ:MBLX) shares have sank by more than 55 percent today after Archer Daniel’s Midland announced that it has terminated its joint venture with the bio-plastics maker. …

Posted in Latest Headlines, Reports | Tagged acquisition, Archer Daniel's, business, Buy, capital, Coal, deal, Department of Justice, diamond foods, DMND, downgrade, financial, Jefferies, Joint Venture, MBLX, Metabolix, NASDAQ, NASDAQ:DMND, NASDAQ:MBLX, NYSE, NYSE:PCX, partnership, Patriot Coal Corp., payments, PCX, Pringles, Procter & Gamble, production, rating, report, shares, walnut growers | Comments Off

What the fuss Emergent Biosolutions, Carrizo Oil & Gas and Dunkin’ Brands?

Posted on December 28, 2011 by Cameron White

In this report: Carrizo Oil & Gas (NASDAQ:CRZO), Dunkin’ Brands Group (NASDAQ:DNKN) and Emergent Biosolutions (NYSE:EBS).

Carrizo Oil & Gas (NASDAQ:CRZO) is trading slightly lower at $25.67 per share today after the company announced that it has acheived its oil …

Posted in Latest Headlines, Reports | Tagged Abbott Laboratories, ABT, Analysts, barres, Carrizo Oil & Gas, clinical, company, CRZO, DA Davidson, DNKN, Dunkin’ Brands Group, EBS, Emergent Biosolutions, firm, forecast, NASDAQ, NASDAQ:CRZO, NASDAQ:DNKN, NYSE, NYSE:ABT, NYSE:EBS, Oil, partnership, portfolio, production, rating, report, share, trading, treatment, upgrade | Comments Off

What the fuss Imax, QuinStreet and Mindray Medical?

Posted on November 8, 2011 by Cameron White

IN THIS ARTICLE: Imax Corp. (NASDAQ:IMAX), QuinStreet Inc. (NASDAQ:QNST) and Mindray Medical International (NYSE:MR).

Imax Corp. (NASDAQ:IMAX) is trading slightly lower today at $19.41 per share. The company announced on Tuesday that it has agreed to install up to seven …

Posted in Latest Headlines, Reports | Tagged Beijing, China, cinemas, company, digital theater, estimates, expectations, expected, forecast, guidance, IMAX, Imax Corp., Mindray Medical International, MR, NASDAQ, NASDAQ:IMAX, NASDAQ:QNST, net income, NYSE, NYSE:MR, partnership, QNST, quarter, QuinStreet Inc., reported, results, revenue, revenue sharing, share, SMI Corp., trading, Wall Street | Comments Off

Big time losers and the reasons why (TRGT, XIDE, AMLN)

Posted on November 8, 2011 by Cameron White

In this report: Targacept Inc. (NASDAQ:TRGT), Exide Technologies (NASDAQ:XIDE) and Amylin Pharmaceuticals (NASDAQ:AMLN).

Targacept Inc. (NASDAQ:TRGT) has dropped by over 56 percent today after the company announced that its experimental drug TC-5214 failed to meet expectations in a trial to …

Posted in Main Post, Reports | Tagged AMLN, Amylin Pharmaceuticals, clinical trial, company, diabetes, drug, Eli Lilly and Co (NYSE:LLY), Exide Technologies, expectations, fiscal, guidance, NASDAQ, NASDAQ:AMLN, NASDAQ:TRGT, NASDAQ:XIDE, net sales, operating income, partnership, patients, payments, Phase 3, preliminary, products, quarter, results, revenue, severe depression, Targacept Inc., therapy, treat, TRGT, trial, XIDA | Comments Off

Whats up Cheniere Energy, Clearwire and Questcor Pharmaceuticals?

Posted on October 26, 2011 by Josie Middleton

In this report: Cheniere Energy Inc. (AMEX:LNG), Clearwire (NASDAQ:CLWR) and Questcor Pharmaceuticals (NASDAQ:QCOR).

Cheniere Energy Inc. (AMEX:LNG) is trading over 46 percent higher today after it announced that it has signed a deal with BG Group PLC from the U.K. …

Posted in Latest Headlines, Reports | Tagged 2012, AMEX, AMEX:LNG, Analysts, BG Group, CEO, Cheniere Energy Inc., Clearwire, CLWR, company, confidence, customers, Dan Hesse, deal, earned, earnings, export, investors, liquid natural gas, LNG, LTE, markets, NASDAQ, NASDAQ:CLWR, NASDAQ:QCOR, net income, NYSE, NYSE:S, partnership, profits, project, QCOR, quarter, Questcor Pharmaceuticals, reported, revenue, S, Sprint Nextel, surge, trading, WiMax | Comments Off

Where the Mayan’s really just talking about Netflix?

Posted on September 2, 2011 by Cameron White

There has been a shroud of uncertainty surrounding the end of the world in 2012 according to the Mayan calendar but could the Mayans have been pointing to the end of Netflix’s monopoly?

Netflix (NASDAQ:NFLX) sunk like a stone …

Posted in Main Post, Technology | Tagged 2012, Amazon.com, AMZN, breakdown, business, collapsed, company, content, deal, DIS, distribution, DVD rental, expires, GOOG, Google, Mayan Calender, Mickey Mouse, monopoly, NASDAQ, NASDAQ:AMZN, nasdaq:goog, NASDAQ:NFLX, negotiations, Netflix, NFLX, NYSE:DIS, NYSE:SNY, online streaming, partnership, profits, renewal, short selling, SNY, Sony, Starz, subscriber, Walt Disney | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.